オンコロジーにおける人工知能（AI）市場レポート 2023-2033
Artificial Intelligence (AI) in Oncology Market Report 2023-2033
レポート詳細
オンコロジーにおける人工知能（AI）市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとな... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
オンコロジーにおける人工知能（AI）市場レポート 2023-2033:本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな地域での既存事業の拡大を希望する企業にとっても有用であろう。
創薬の加速と標的治療が市場成長を牽引
AI技術は、大量のデータとスマートなアルゴリズムを活用することで、がんにおける医薬品の研究開発プロセスを変革しつつある。こうした開発により、有望な薬剤候補の同定を迅速化し、その有効性を向上させ、標的医薬品の開発を容易にしようとしている。医薬品開発におけるAIは、従来の手法に伴う時間と費用を劇的に削減する可能性を秘めている。
AIを活用した創薬・開発プラットフォームやツールの開発により、製薬企業、テクノロジー企業、学術機関のコラボレーションが活発化している。こうした共同研究は、AIを活用して新たながん治療薬の開発を加速させようとしている。例えば、2023年5月、シドニー大学とオーストラリア企業のファロス・セラピューティクスは、がんや一般的でない疾患の治療のための創薬を進めるためにAIを活用することに合意した。
標準化の欠如が大きな障壁に
標準化されたデータ収集とアノテーションの実践は、オンコロジーにおけるAI主導の研究とケアにおいて極めて重要である。データ収集方法、フォーマット、注釈プロトコルのばらつきは、AIアルゴリズムの性能と一般化可能性に影響を与える可能性がある。これらのプロセスを標準化することで、データの品質と一貫性を向上させ、より堅牢なAIモデルを実現することができる。標準化はまた、データの共有、コラボレーション、再現性を促進し、この分野における有意義な比較と進歩を可能にする。
例えば、Cancer Imaging Archive (TCIA)やDigital Imaging and Communications in Medicine (DICOM)のような業界主導のコンソーシアムのような、医療機関とテクノロジー企業間の協力的な取り組みは、腫瘍画像診断におけるデータ共有、保存、注釈の実践の標準化に向けて努力している。これらのイニシアチブは、データ収集、アルゴリズム開発、評価のための標準化されたガイドラインとプロトコルの使用を促進する。
オンコロジーにおけるAI標準化の欠如に取り組むことで、関係者は市場成長の障壁を克服することができる。データ収集、アルゴリズム開発、評価のための包括的な枠組みやガイドラインを確立するには、共同イニシアチブ、業界パートナーシップ、規制ガイダンスが不可欠である。このような取り組みにより、データ収集方法、フォーマット、注釈プロトコルが、異なる医療機関や研究機関間で一貫し、調和されることが保証される。
市場調査レポートを購入する前にすべき質問とは？
- オンコロジーにおけるAI市場はどのように進化しているのか？
- オンコロジーにおけるAI市場の推進要因と抑制要因は何か？
- オンコロジーにおけるAIサブマーケットの各セグメントは予測期間中にどのように成長し、2033年にはどれくらいの収益を占めるようになるのか？
- 2023年から2033年にかけて、オンコロジーにおける各AIサブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて市場全体の主な牽引役は何か？
- オンコロジーにおける主要AI市場はマクロ経済の動きに大枠で追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これらの主要企業におけるオンコロジーにおけるAIプロジェクトとは？
- 2023年から2033年の間に、業界はどのように進化するのか？現在および今後10年間に行われるオンコロジーにおけるAIプロジェクトにはどのような意味があるのか？
- オンコロジーにおけるAI市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
- オンコロジーにおけるAI市場はどこに向かい、どのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長路線とC-suiteに移行させるための重要な展望とは？
このことが、現在、そして今後10年間、オンコロジーにおけるAI市場にどのような影響を与えるかを見極める必要がある：
- 289ページにわたる本レポートでは、123の表と163の図表を掲載しています。
- 本レポートは、業界における主要な有利分野にハイライトを当てているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、オンコロジーにおけるAI市場が今後10年間でどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展するかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。
2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、オンコロジーにおけるAI価格上昇の影響、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
製品タイプ
- ソフトウェア
- ハードウェア
- サービス
利用タイプ
- がん研究
- 事前スクリーニングと診断
- 治療
疾患タイプ
- 肺がん
- 乳がん
- 前立腺がん
- 大腸がん
- その他
エンドユーザー
- 製薬会社およびバイオ製薬会社
- 研究機関
- 病院・診断センター
- その他
世界市場全体とセグメント別の収益予測に加え、5つの地域と20の主要国市場の収益予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- ロシア
- その他のヨーロッパ
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- シンガポール
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他のラテンアメリカ
MEA
- GCC
- 南アフリカ
- その他のMEA
本レポートでは、オンコロジーにおけるAI市場の2023年から2033年にかけての主要企業のプロファイルも掲載している。
主要企業と市場成長の可能性
・ Azra AI
・ Botkin.AI
・ CloudMedX Health
・ ConcertAI
・ Digital Diagnostics AI
・ Enlitic
・ GE Healthcare
・ Google Health
・ IBM Corporation
・ iCAD
・ Intel Corporation
・ NVIDIA
・ Owkin
・ Siemen’s Healthineers
・ SkinVision
・ Therapixel
オンコロジーにおけるAI市場全体の世界売上高、2023～2033年、金額ベースでは2023年に26億1,760万USドルを突破する、との試算がある。2033年まで力強い収益成長を予測している。当研究所では、最も大きな可能性を秘めた組織を特定している。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。
オンコロジーにおけるAI市場、2023〜2033年」レポートはどのように役立つのか？
要約すると、280ページを超えるこのレポートは、以下の知識を提供する：
- オンコロジーにおけるAI市場の2023年から2033年までの収益予測 製品タイプ、用途タイプ、疾患タイプ、エンドユーザータイプ別に、世界レベルと地域レベルで予測 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
- 5つの地域と20の主要国市場の2033年までの収益予測 - オンコロジーにおけるAI市場、北米、欧州、アジア太平洋、中南米、MEAの2023年から2033年までの市場予測をご覧ください。また、米国、カナダ、ドイツ、英国、フランス、スペイン、イタリア、ロシア、中国、インド、日本、オーストラリア、韓国、シンガポール、ブラジル、メキシコ、アルゼンチン、コロンビア、GCC、南アフリカ、その他著名な経済圏の市場も予測しています。
- 既存企業および市場参入を目指す企業の展望 - オンコロジーにおけるAI市場（2023年～2033年）に関わる主要企業16社の企業プロファイルを含む。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社の調査結果が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、オンコロジーにおけるAI市場、2023年から2033年、市場をリードする企業の商業的分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 がん領域におけるAI市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場牽引要因
3.2.1.1 早期発見・診断ががん領域におけるAiの成長を促進
3.2.1.2 AI技術のブレークスルーによる精度と効率の向上
3.2.1.3 大規模かつ複雑な医療データセットの生成が市場を牽引
3.2.2 市場抑制要因
3.2.2.1 データのセキュリティとプライバシーに関する懸念が大きな障壁となっている
3.2.2.2 熟練したAI人材の不足とコスト・インフラ要件が大きな課題となっている
3.2.3 市場機会
3.2.3.1 遠隔モニタリングと遠隔医療のニーズの高まり
3.2.3.2 個別化された投薬に対する需要の増加が市場拡大を促進
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 オンコロジーにおけるAI市場分析：製品タイプ別
4.1 主要な調査結果
4.2 製品タイプセグメント 市場魅力度指数
4.3 製品タイプ別オンコロジーにおけるAI市場規模の推定と予測
4.4 ソフトウェア
4.4.1 2023〜2033年の地域別市場規模（US$ Million）
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 ハードウェア
4.5.1 2023～2033年の地域別市場規模（US$ Million）
4.5.2 地域別市場シェア、2023年・2033年(%)
4.6 サービス
4.6.1 2023～2033年の地域別市場規模（US$ Million）
4.6.2 地域別市場シェア、2023年・2033年(%)
5 オンコロジーにおけるAI市場分析：用途タイプ別
5.1 主な調査結果
5.2 用途タイプ別セグメント市場魅力度指数
5.3 オンコロジーにおけるAI利用タイプ別市場規模推定と予測
5.4 がん研究
5.4.1 2023〜2033年の地域別市場規模（US$ Million）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 事前スクリーニングと診断
5.5.1 2023〜2033年の地域別市場規模（US$ Million）
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 治療
5.6.1 2023～2033年の地域別市場規模（US$ Million）
5.6.2 地域別市場シェア、2023年・2033年(%)
6 オンコロジーにおけるAI市場分析：エンドユーザー別
6.1 主要調査結果
6.2 エンドユーザーセグメント 市場魅力度指数
6.3 オンコロジーにおけるAIエンドユーザー別市場規模推定と予測
6.4 製薬・バイオ医薬品企業
6.4.1 2023〜2033年の地域別市場規模（US$ Million）
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 研究機関
6.5.1 2023～2033年の地域別市場規模（US$ Million）
6.5.2 地域別市場シェア、2023年・2033年(%)
6.6 病院・診断センター
6.6.1 2023～2033年の地域別市場規模（US$ Million）
6.6.2 地域別市場シェア、2023年・2033年(%)
6.7 その他
6.7.1 2023〜2033年の地域別市場規模（US$ Million）
6.7.2 地域別市場シェア、2023年・2033年 (%)
7 オンコロジーにおけるAI市場分析：疾患タイプ別
7.1 主要な調査結果
7.2 疾患タイプセグメント 市場魅力度指数
7.3 オンコロジーにおけるAI市場疾患タイプ別市場規模推定と予測
7.4 肺がん
7.4.1 2023〜2033年の地域別市場規模（US$ Million）
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 乳がん
7.5.1 2023〜2033年の地域別市場規模（US$ Million）
7.5.2 地域別市場シェア、2023年・2033年(%)
7.6 前立腺がん
7.6.1 2023〜2033年の地域別市場規模（US$ Million）
7.6.2 地域別市場シェア、2023年・2033年(%)
7.7 結腸癌
7.7.1 2023〜2033年の地域別市場規模（US$ Million）
7.7.2 地域別市場シェア、2023年・2033年(%)
7.8 その他
7.8.1 2023〜2033年の地域別市場規模（US$ Million）
7.8.2 地域別市場シェア、2023年・2033年(%)
8 オンコロジーにおけるAI市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測
9 北米のオンコロジーにおけるAI市場分析
9.1 主要な調査結果
9.2 北米のオンコロジーにおけるAI市場魅力度指数
9.3 北米のオンコロジーにおけるAI市場国別、2023年、2028年、2033年（US$ Million）
9.4 北米のオンコロジーにおけるAI市場規模推定と予測：国別
9.5 北米のオンコロジーにおけるAI市場規模推定と予測：製品タイプ別
9.6 北米のオンコロジーにおけるAI市場規模推定と予測：用途タイプ別
9.7 北米のオンコロジーにおけるAI市場規模推定と予測：エンドユーザー別
9.8 北米のオンコロジーにおけるAI市場規模推定と予測：疾患タイプ別
9.9 米国のオンコロジーにおけるAI市場分析
9.10 カナダのオンコロジーにおけるAI市場分析
10 欧州のオンコロジーにおけるAI市場分析
10.1 主要な調査結果
10.2 欧州のオンコロジーにおけるAI市場魅力度指数
10.3 欧州のオンコロジーにおけるAI国別市場、2023年、2028年、2033年 （US$ Million）
10.4 欧州のオンコロジーにおけるAI市場規模推定と予測：国別
10.5 欧州のオンコロジーにおけるAI市場規模推定と予測：製品タイプ別
10.6 欧州のオンコロジーにおけるAI市場規模推定と予測：用途タイプ別
10.7 欧州のオンコロジーにおけるAI市場規模推定と予測：エンドユーザー別
10.8 欧州のオンコロジーにおけるAI市場規模推定と予測：疾患タイプ別
10.9 ドイツのオンコロジーにおけるAI市場分析
10.10 フランスのオンコロジーにおけるAI市場分析
10.11 イギリスのオンコロジーにおけるAI市場分析
10.12 イタリアのオンコロジーにおけるAI市場分析
10.13 スペインのオンコロジーにおけるAI市場分析
10.14 ロシアのオンコロジーにおけるAI市場分析
10.15 その他の欧州のオンコロジーにおけるAI市場分析
11 アジア太平洋地域のオンコロジーにおけるAI市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域のオンコロジーにおけるAI市場魅力度指数
11.3 アジア太平洋地域のオンコロジーにおけるAI市場国別、2023年、2028年、2033年（US$ Million）
11.4 アジア太平洋地域のオンコロジーにおけるAI市場規模推定と予測：国別
11.5 アジア太平洋地域のオンコロジーにおけるAI市場規模推定と予測：製品タイプ別
11.6 アジア太平洋地域のオンコロジーにおけるAI市場規模推定と予測：用途タイプ別
11.7 アジア太平洋地域のオンコロジーにおけるAI市場規模推定と予測：エンドユーザー別
11.8 アジア太平洋地域のオンコロジーにおけるAI市場規模推定と予測：疾患タイプ別
11.9 日本のオンコロジーにおけるAI市場分析
11.10 中国 オンコロジーにおけるAI市場分析
11.11 インドのオンコロジーにおけるAI市場分析
11.12 オーストラリアのオンコロジーにおけるAI市場分析
11.13 韓国のオンコロジーにおけるAI市場分析
11.14 シンガポールのオンコロジーにおけるAI市場分析
11.15 その他のアジア太平洋地域のオンコロジーにおけるAI市場分析
12 ラテンアメリカのオンコロジーにおけるAI市場分析
12.1 主要な調査結果
12.2 ラテンアメリカのオンコロジーにおけるAI市場魅力度指数
12.3 ラテンアメリカのオンコロジーにおけるAI市場国別、2023年、2028年、2033年 （US$ Million）
12.4 ラテンアメリカのオンコロジーにおけるAI市場規模推定と予測：国別
12.5 ラテンアメリカのオンコロジーにおけるAI市場規模推定と予測：製品タイプ別
12.6 ラテンアメリカのオンコロジーにおけるAI市場規模推定と予測：用途タイプ別
12.7 ラテンアメリカのオンコロジーにおけるAI市場規模推定と予測：エンドユーザー別
12.8 ラテンアメリカのオンコロジーにおけるAI市場規模推定と予測：疾患タイプ別
12.9 ブラジルのオンコロジーにおけるAI市場分析
12.10 メキシコのオンコロジーにおけるAI市場分析
12.11 アルゼンチンのオンコロジーにおけるAI市場の分析
12.12 コロンビアのオンコロジーにおけるAI市場分析
12.13 その他のラテンアメリカのオンコロジーにおけるAI市場分析
13 MEAのオンコロジーにおけるAI市場分析
13.1 主要な調査結果
13.2 MEAのオンコロジーにおけるAI市場魅力度指数
13.3 オンコロジーにおけるMEAの国別AI市場,2023年、2028年、2033年（US$ Million）
13.4 MEAのオンコロジーにおけるAI市場規模推定と予測：国別
13.5 MEAのオンコロジーにおけるAI市場規模推定と予測：製品タイプ別
13.6 MEAのオンコロジーにおけるAI市場規模推定と予測：用途タイプ別
13.7 MEAのオンコロジーにおけるAI市場規模推定と予測：エンドユーザー別
13.8 MEAのオンコロジーにおけるAI市場規模推定と予測：疾患タイプ別
13.9 GCCのオンコロジーにおけるAI市場分析
13.10 南アフリカのオンコロジーにおけるAI市場分析
13.11 その他のMEAのオンコロジーにおけるAI市場分析
14 主要企業のプロファイル
14.1 競争環境、2022年
14.2 戦略的展望
14.3 IBM Corporation
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2017-2022年
14.3.3.2 R＆D、2017年～2022年
14.3.3.3 地域市場シェア、2022年
14.3.4 製品ベンチマーク
14.3.5 戦略的展望
14.4 GE Healthcare
14.4.1 会社概要
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収入、2019-2022年
14.4.3.2 R＆D、2019-2022年
14.4.3.3 地域市場シェア、2022年
14.4.4 製品ベンチマーク
14.4.5 戦略的展望
14.5 iCAD
14.5.1 会社概要
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収入、2017-2022年
14.5.3.2 R＆D、2017-2022年
14.5.4 製品ベンチマーク
14.5.5 戦略的展望
14.6 Siemen's Healthineers
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収入、2018-2022年
14.6.3.2 売上高、2018-2022年
14.6.4 製品ベンチマーク
14.6.5 戦略的展望
14.7 Google Health
14.7.1 会社概要
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収入、2017-2022年
14.7.3.2 売上高、2017-2022年
14.7.4 製品ベンチマーク
14.7.5 戦略的展望
14.8 Intel Corporation
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収入、2017-2022年
14.8.3.2 売上高、2017-2022年
14.8.4 製品ベンチマーク
14.8.5 戦略的展望
14.9 NVIDIA
14.9.1 会社概要
14.9.2 会社概要
14.9.3 財務分析
14.9.3.1 純収入、2017-2022年
14.9.3.2 R＆D、2017年～2022年
14.9.3.3 地域市場シェア、2022年
14.9.4 製品ベンチマーク
14.9.5 サービスのベンチマーキング
14.9.6 戦略的展望
14.10 Azra AI
14.10.1 会社概要
14.10.2 会社概要
14.10.3 製品ベンチマーク
14.10.4 戦略的展望
14.11 ConcertAI
14.11.1 会社概要
14.11.2 会社概要
14.11.3 製品ベンチマーク
14.11.4 サービスベンチマーク
14.11.5 戦略的展望
14.12 Digital Diagnostics
14.12.1 会社概要
14.12.2 会社概要
14.12.3 製品ベンチマーク
14.12.4 戦略的展望
14.13 CloudMedX Health
14.13.1 会社概要
14.13.2 会社概要
14.13.3 製品ベンチマーク
14.13.4 戦略的展望
14.14 Enlitic
14.14.1 会社概要
14.14.2 会社概要
14.14.3 製品ベンチマーキング
14.14.4 サービス・ベンチマーク
14.14.5 戦略的展望
14.15 SkinVision
14.15.1 会社概要
14.15.2 会社概要
14.15.3 製品ベンチマーク
14.15.4 戦略的展望
14.16 Therapixel
14.16.1 会社概要
14.16.2 会社概要
14.16.3 製品ベンチマーク
14.16.4 戦略的展望
14.17 Botkin.AI
14.17.1 会社概要
14.17.2 会社概要
14.17.3 製品ベンチマーク
14.17.4 戦略的展望
14.18 Botkin.AI
14.18.1 会社概要
14.18.2 会社概要
14.18.3 製品ベンチマーク
14.18.4 戦略的展望
15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 AI in Oncology Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Hardware Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Cancer Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Pre-screening and Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Hospitals and Diagnostic Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Lung Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Breast Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Prostate Cancer Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Colon Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 North America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 U.S. AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Canada AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Europe AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 34 Europe AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Germany AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 France AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 UK AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Italy AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Spain AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Russia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Rest of Europe AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Asia Pacific AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Japan AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 China AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 India AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Australia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 South Korea AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 55 Singapore AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 56 Rest of Asia Pacific AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Latin America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Brazil AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Mexico AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Argentina AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 65 Colombia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 66 Rest of Latin America AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 IBM Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IBM Corporation: Product Benchmarking
Table 78 IBM Corporation: Product
Table 79 IBM Corporation: Strategic Outlook
Table 80 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 GE Healthcare: Product Benchmarking
Table 82 GE Healthcare: Strategic Outlook
Table 83 iCAD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 iCAD: Product Benchmarking
Table 85 iCAD: Strategic Outlook
Table 86 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Google Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Google: Product Benchmarking
Table 89 Google: Strategic Outlook
Table 90 Intel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Intel: Product Benchmarking
Table 92 Intel: Strategic Outlook
Table 93 NVIDIA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 NVIDIA: Product Benchmarking
Table 95 NVIDIA: Product Benchmarking
Table 96 NVIDIA: Strategic Outlook
Table 97 Azra AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Azra AI: Product Benchmarking
Table 99 Azra AI: Strategic Outlook
Table 100 ConcertAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ConcertAI: Product Benchmarking
Table 102 ConcertAI: Service Benchmarking
Table 103 ConcertAI: Strategic Outlook
Table 104 Digital Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Digital Diagnostics: Product Benchmarking
Table 106 Digital Diagnostics: Strategic Outlook
Table 107 CloudMedX Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 CloudMedx Health: Product Benchmarking
Table 109 CloudMedx Health: Strategic Outlook
Table 110 Enlitic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Enlitic: Product Benchmarking
Table 112 Enlitic: Service Benchmarking
Table 113 Enlitic: Strategic Outlook
Table 114 SkinVision: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 SkinVision: Product Benchmarking
Table 116 SkinVision : Strategic Outlook
Table 117 Owkin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Therapixel: Product Benchmarking
Table 119 Therapixel: Strategic Outlook
Table 120 Botkin.AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Botkin.AI: Product Benchmarking
Table 122 Botkin.AI: Strategic Outlook
Table 123 Owkin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Owkin: Product Benchmarking
Table 125 Owkin: Strategic Outlook
図の一覧
Figure 1 AI in Oncology Market Segmentation
Figure 2 AI in Oncology Market by Product Type: Market Attractiveness Index
Figure 3 AI in Oncology Market by Usage Type: Market Attractiveness Index
Figure 4 AI in Oncology Market by Disease Type: Market Attractiveness Index
Figure 5 AI in Oncology Market by End-user: Market Attractiveness Index
Figure 6 AI in Oncology Market Attractiveness Index by Region
Figure 7 AI in Oncology Market: Market Dynamics
Figure 8 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 AI in Oncology Market: Porter’s Five Forces Analysis
Figure 13 AI in Oncology Market: PEST Analysis
Figure 14 AI in Oncology Market by Product Type: Market Attractiveness Index
Figure 15 AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 16 AI in Oncology Market Share Forecast by Product Type, 2023, 2028, 2033 (%)
Figure 17 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Software Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Hardware Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Hardware Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 AI in Oncology Market by Usage Type: Market Attractiveness Index
Figure 24 AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 25 AI in Oncology Market Share Forecast by Usage Type, 2023, 2028, 2033 (%)
Figure 26 Cancer Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Cancer Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Pre-screening and Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Pre-screening and Diagnosis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Treatment Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 AI in Oncology Market by End-user: Market Attractiveness Index
Figure 33 AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 34 AI in Oncology Market Share Forecast by End-user, 2023, 2028, 2033 (%)
Figure 35 Pharmaceutical and Biopharmaceutical Companies Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Hospital and Diagnostic Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Hospital and Diagnostic Centres Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 AI in Oncology Market by Disease Type: Market Attractiveness Index
Figure 44 AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 45 AI in Oncology Market Share Forecast by Disease Type, 2023, 2028, 2033 (%)
Figure 46 Lung Cancer Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 47 Lung Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Breast Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 49 Breast Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Prostate Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 51 Prostate Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Colon Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Colon Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 AI in Oncology Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 57 AI in Oncology Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 58 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 North America AI in Oncology Market Attractiveness Index
Figure 60 North America AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 61 North America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 62 North America AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 64 North America AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 65 North America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 66 North America AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 67 North America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 68 North America AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 69 North America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 70 North America AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 71 U.S. AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Canada AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe AI in Oncology Market Attractiveness Index
Figure 74 Europe AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 75 Europe AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 76 Europe AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 78 Europe AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 79 Europe AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 81 Europe AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 83 Europe AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 85 Germany AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 France AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 UK AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Italy AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Spain AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Russia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Rest of Europe AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Asia Pacific AI in Oncology Market Attractiveness Index
Figure 93 Asia Pacific AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 94 Asia Pacific AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 95 Asia Pacific AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 Asia Pacific AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 97 Asia Pacific AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 98 Asia Pacific AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia Pacific AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 100 Asia Pacific AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 102 Asia Pacific AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 104 Japan AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 China AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 India AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Australia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 South Korea AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Singapore AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 Rest of Asia Pacific AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Latin America AI in Oncology Market Attractiveness Index
Figure 112 Latin America AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 113 Latin America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 115 Latin America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 117 Latin America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 119 Latin America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 120 Latin America AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 121 Latin America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 122 Latin America AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 123 Brazil AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 Mexico AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 Argentina AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Colombia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Rest of Latin America AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 MEA AI in Oncology Market Attractiveness Index
Figure 129 MEA AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 130 MEA AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 132 MEA AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 133 MEA AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 134 MEA AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 136 MEA AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 138 MEA AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 140 GCC AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 South Africa AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Rest of MEA AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 AI in Oncology Market: Company Share/Ranking, 2022
Figure 144 IBM Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 145 IBM: R&D, 2017-2022 (US$ Million, AGR %)
Figure 146 IBM: Regional Market Shares, 2022
Figure 147 GE Healthcare: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 148 GE Healthcare: R&D, 2019-2022 (US$ Million, AGR%)
Figure 149 GE Healthcare: Regional Market Shares, 2022
Figure 150 iCAD: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 151 iCAD: R&D, 2017-2022 (US$ Million, AGR%)
Figure 152 Siemens Healthineers: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 153 Siemens Healthineers: R&D, 2018-2022 (US$ Million, AGR%)
Figure 154 Siemens Healthineers: Product Benchmarking
Figure 155 Siemens Healthineers: Strategic Outlook
Figure 156 Google: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 157 Google: R&D, 2017-2022 (US$ Million, AGR%)
Figure 158 Intel: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 159 Intel: R&D, 2017-2022 (US$ Million, AGR%)
Figure 160 NVIDIA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 161 NVIDIA: R&D, 2017-2022 (US$ Million, AGR%)
Figure 162 NVIDIA: Regional Market Shares, 2022
ページTOPに戻る
Summary
Report Details
The Artificial Intelligence (AI) in Oncology Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Accelerated Drug Discovery and Targeted Therapies Driving Market Growth
AI technologies are transforming the drug research and development process in cancer by harnessing massive volumes of data and smart algorithms. These developments seek to speed up the identification of prospective medication candidates, improve their efficacy, and make the development of targeted medicines easier. AI in drug development has the potential to dramatically reduce the time and expense associated with traditional techniques.
Collaborations between pharmaceutical corporations, technology businesses, and academic institutions have increased as a result of the development of AI-driven platforms and tools for drug discovery and development. These collaborations attempt to use AI to accelerate the development of new cancer medicines. For instance, in May 2023, the University of Sydney and the Australian business Pharos Therapeutics agreed to use AI to advance medication discovery for the treatment of cancer and uncommon disorders.
Lack of Standardization causes significant barriers
Standardized data collection and annotation practices are crucial in AI-driven oncology research and care. Variations in data collection methods, formats, and annotation protocols can impact the performance and generalizability of AI algorithms. By standardizing these processes, the quality and consistency of data can be improved, leading to more robust AI models. Standardization also facilitates data sharing, collaboration, and reproducibility, enabling meaningful comparisons and advancements in the field.
For instance, collaborative efforts between healthcare institutions and technology companies, such as the Cancer Imaging Archive (TCIA) and industry-led consortia like the Digital Imaging and Communications in Medicine (DICOM) are striving towards standardizing data sharing, storage, and annotation practices in oncology imaging. These initiatives promote the use of standardized guidelines and protocols for data collection, algorithm development, and evaluation.
By addressing the lack of standardization in AI oncology, stakeholders can overcome barriers to market growth. Collaborative initiatives, industry partnerships, and regulatory guidance are essential to establish comprehensive frameworks and guidelines for data collection, algorithm development, and evaluation. These efforts ensure that data collection methods, formats, and annotation protocols are consistent and harmonized across different healthcare institutions and research organizations.
What Questions Should You Ask before Buying a Market Research Report?
• How is the AI in oncology market evolving?
• What is driving and restraining the AI in oncology market?
• How will each AI in oncology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each AI in oncology submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading AI in oncology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the AI in oncology projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of AI in oncology projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the AI in oncology market?
• Where is the AI in oncology market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the AI in oncology market today, and over the next 10 years:
• Our 289-page report provides 123 tables and 163 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the AI in oncology market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI in oncology prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Product Type
• Software
• Hardware
• Services
Usage Type
• Cancer Research
• Pre-screening and Diagnosis
• Treatment
Disease Type
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colon Cancer
• Others
End-users
• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes
• Hospitals and Diagnostic Centres
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the AI in Oncology Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Azra AI
• Botkin.AI
• CloudMedX Health
• ConcertAI
• Digital Diagnostics AI
• Enlitic
• GE Healthcare
• Google Health
• IBM Corporation
• iCAD
• Intel Corporation
• NVIDIA
• Owkin
• Siemen’s Healthineers
• SkinVision
• Therapixel
Overall world revenue for AI in oncology market, 2023 to 2033 in terms of value the market will surpass US$2,617.6 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the AI in Oncology Market, 2023 to 2033 report help you?
In summary, our 280+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for AI in Oncology Market, 2023 to 2033 Market, with forecasts for product types, usage types, disease types and end-users types, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the AI in Oncology Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, South Korea, Singapore, Brazil, Mexico, Argentina, Colombia, GCC, South Africa, and among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the AI in Oncology Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the AI in oncology Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to AI in Oncology Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Early Detection and Diagnosis Fuelling the Growth of Ai in Oncology
3.2.1.2 AI Technology Breakthroughs Improved Accuracy and Efficiency
3.2.1.3 Generation of Large And Complex Healthcare Datasets In Driving The Market
3.2.2 Market Restraining Factors
3.2.2.1 Security and Privacy of Data Concerns Causes Significant Barriers
3.2.2.2 Lack Of Skilled AI Workforce and Cost And Infrastructure Requirement Pose Significant Challenges
3.2.3 Market Opportunities
3.2.3.1 Rising Need Of Remote Monitoring And Telemedicine
3.2.3.2 Increasing Demand For Personalised Medication Is Driving Market Expansion
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 AI in Oncology Market Analysis by Product Type
4.1 Key Findings
4.2 Product Type Segment: Market Attractiveness Index
4.3 AI in Oncology Market Size Estimation and Forecast by Product Type
4.4 Software
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Hardware
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Services
4.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.2 Market Share by Region, 2023 & 2033 (%)
5 AI in Oncology Market Analysis by Usage Type
5.1 Key Findings
5.2 Usage Type Segment: Market Attractiveness Index
5.3 AI in Oncology Market Size Estimation and Forecast by Usage Type
5.4 Cancer Research
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Pre-screening and Diagnosis
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Treatment
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 AI in Oncology Market Analysis by End-user
6.1 Key Findings
6.2 End-user Segment: Market Attractiveness Index
6.3 AI in Oncology Market Size Estimation and Forecast by End-user
6.4 Pharmaceutical and Biopharmaceutical Companies
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Research Institutes
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Hospitals and Diagnostic Centres
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Others
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
7 AI in Oncology Market Analysis by Disease Type
7.1 Key Findings
7.2 Disease Type Segment: Market Attractiveness Index
7.3 AI in Oncology Market Size Estimation and Forecast by Disease Type
7.4 Lung Cancer
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Breast Cancer
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Prostate Cancer
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Colon Cancer
7.7.1 Market Size by Region, 2023-2033 (US$ Million)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Others
7.8.1 Market Size by Region, 2023-2033 (US$ Million)
7.8.2 Market Share by Region, 2023 & 2033 (%)
8 AI in Oncology Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America AI in Oncology Market Analysis
9.1 Key Findings
9.2 North America AI in Oncology Market Attractiveness Index
9.3 North America AI in Oncology Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America AI in Oncology Market Size Estimation and Forecast by Country
9.5 North America AI in Oncology Market Size Estimation and Forecast by Product Type
9.6 North America AI in Oncology Market Size Estimation and Forecast by Usage Type
9.7 North America AI in Oncology Market Size Estimation and Forecast by End-user
9.8 North America AI in Oncology Market Size Estimation and Forecast by Disease Type
9.9 U.S. AI in Oncology Market Analysis
9.10 Canada AI in Oncology Market Analysis
10 Europe AI in Oncology Market Analysis
10.1 Key Findings
10.2 Europe AI in Oncology Market Attractiveness Index
10.3 Europe AI in Oncology Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe AI in Oncology Market Size Estimation and Forecast by Country
10.5 Europe AI in Oncology Market Size Estimation and Forecast by Product Type
10.6 Europe AI in Oncology Market Size Estimation and Forecast by Usage Type
10.7 Europe AI in Oncology Market Size Estimation and Forecast by End-user
10.8 Europe AI in Oncology Market Size Estimation and Forecast by Disease Type
10.9 Germany AI in Oncology Market Analysis
10.10 France AI in Oncology Market Analysis
10.11 UK AI in Oncology Market Analysis
10.12 Italy AI in Oncology Market Analysis
10.13 Spain AI in Oncology Market Analysis
10.14 Russia AI in Oncology Market Analysis
10.15 Rest of Europe AI in Oncology Market Analysis
11 Asia Pacific AI in Oncology Market Analysis
11.1 Key Findings
11.2 Asia Pacific AI in Oncology Market Attractiveness Index
11.3 Asia Pacific AI in Oncology Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific AI in Oncology Market Size Estimation and Forecast by Country
11.5 Asia Pacific AI in Oncology Market Size Estimation and Forecast by Product Type
11.6 Asia Pacific AI in Oncology Market Size Estimation and Forecast by Usage Type
11.7 Asia Pacific AI in Oncology Market Size Estimation and Forecast by End-user
11.8 Asia Pacific AI in Oncology Market Size Estimation and Forecast by Disease Type
11.9 Japan AI in Oncology Market Analysis
11.10 China AI in Oncology Market Analysis
11.11 India AI in Oncology Market Analysis
11.12 Australia AI in Oncology Market Analysis
11.13 South Korea AI in Oncology Market Analysis
11.14 Singapore AI in Oncology Market Analysis
11.15 Rest of Asia Pacific AI in Oncology Market Analysis
12 Latin America AI in Oncology Market Analysis
12.1 Key Findings
12.2 Latin America AI in Oncology Market Attractiveness Index
12.3 Latin America AI in Oncology Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America AI in Oncology Market Size Estimation and Forecast by Country
12.5 Latin America AI in Oncology Market Size Estimation and Forecast by Product Type
12.6 Latin America AI in Oncology Market Size Estimation and Forecast by Usage Type
12.7 Latin America AI in Oncology Market Size Estimation and Forecast by End-user
12.8 Latin America AI in Oncology Market Size Estimation and Forecast by Disease Type
12.9 Brazil AI in Oncology Market Analysis
12.10 Mexico AI in Oncology Market Analysis
12.11 Argentina AI in Oncology Market Analysis
12.12 Colombia AI in Oncology Market Analysis
12.13 Rest of Latin America AI in Oncology Market Analysis
13 MEA AI in Oncology Market Analysis
13.1 Key Findings
13.2 MEA AI in Oncology Market Attractiveness Index
13.3 MEA AI in Oncology Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA AI in Oncology Market Size Estimation and Forecast by Country
13.5 MEA AI in Oncology Market Size Estimation and Forecast by Product Type
13.6 MEA AI in Oncology Market Size Estimation and Forecast by Usage Type
13.7 MEA AI in Oncology Market Size Estimation and Forecast by End-user
13.8 MEA AI in Oncology Market Size Estimation and Forecast by Disease Type
13.9 GCC AI in Oncology Market Analysis
13.10 South Africa AI in Oncology Market Analysis
13.11 Rest of MEA AI in Oncology Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 IBM Corporation
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 GE Healthcare
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2019-2022
14.4.3.2 R&D, 2019-2022
14.4.3.3 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 iCAD
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 R&D, 2017-2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Siemen's Healthineers
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2022
14.6.3.2 R&D, 2018-2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Google Health
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 R&D, 2017-2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Intel Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 R&D, 2017-2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 NVIDIA
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2022
14.9.3.2 R&D, 2017-2022
14.9.3.3 Regional Market Shares, 2022
14.9.4 Product Benchmarking
14.9.5 Service Benchmarking
14.9.6 Strategic Outlook
14.10 Azra AI
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 ConcertAI
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Service Benchmarking
14.11.5 Strategic Outlook
14.12 Digital Diagnostics
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.12.4 Strategic Outlook
14.13 CloudMedX Health
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Enlitic
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.14.4 Service Benchmarking
14.14.5 Strategic Outlook
14.15 SkinVision
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.15.4 Strategic Outlook
14.16 Therapixel
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.16.4 Strategic Outlook
14.17 Botkin.AI
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
14.17.4 Strategic Outlook
14.18 Owkin
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Product Benchmarking
14.18.4 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 AI in Oncology Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Hardware Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Cancer Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Pre-screening and Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Hospitals and Diagnostic Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Lung Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Breast Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Prostate Cancer Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Colon Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 AI in Oncology Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 North America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 U.S. AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Canada AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Europe AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 34 Europe AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Germany AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 France AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 UK AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Italy AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Spain AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Russia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Rest of Europe AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Asia Pacific AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Japan AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 China AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 India AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Australia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 South Korea AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 55 Singapore AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 56 Rest of Asia Pacific AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Latin America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Brazil AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Mexico AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Argentina AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 65 Colombia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 66 Rest of Latin America AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 IBM Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IBM Corporation: Product Benchmarking
Table 78 IBM Corporation: Product
Table 79 IBM Corporation: Strategic Outlook
Table 80 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 GE Healthcare: Product Benchmarking
Table 82 GE Healthcare: Strategic Outlook
Table 83 iCAD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 iCAD: Product Benchmarking
Table 85 iCAD: Strategic Outlook
Table 86 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Google Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Google: Product Benchmarking
Table 89 Google: Strategic Outlook
Table 90 Intel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Intel: Product Benchmarking
Table 92 Intel: Strategic Outlook
Table 93 NVIDIA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 NVIDIA: Product Benchmarking
Table 95 NVIDIA: Product Benchmarking
Table 96 NVIDIA: Strategic Outlook
Table 97 Azra AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Azra AI: Product Benchmarking
Table 99 Azra AI: Strategic Outlook
Table 100 ConcertAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ConcertAI: Product Benchmarking
Table 102 ConcertAI: Service Benchmarking
Table 103 ConcertAI: Strategic Outlook
Table 104 Digital Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Digital Diagnostics: Product Benchmarking
Table 106 Digital Diagnostics: Strategic Outlook
Table 107 CloudMedX Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 CloudMedx Health: Product Benchmarking
Table 109 CloudMedx Health: Strategic Outlook
Table 110 Enlitic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Enlitic: Product Benchmarking
Table 112 Enlitic: Service Benchmarking
Table 113 Enlitic: Strategic Outlook
Table 114 SkinVision: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 SkinVision: Product Benchmarking
Table 116 SkinVision : Strategic Outlook
Table 117 Owkin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Therapixel: Product Benchmarking
Table 119 Therapixel: Strategic Outlook
Table 120 Botkin.AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Botkin.AI: Product Benchmarking
Table 122 Botkin.AI: Strategic Outlook
Table 123 Owkin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Owkin: Product Benchmarking
Table 125 Owkin: Strategic Outlook
List of Figures
Figure 1 AI in Oncology Market Segmentation
Figure 2 AI in Oncology Market by Product Type: Market Attractiveness Index
Figure 3 AI in Oncology Market by Usage Type: Market Attractiveness Index
Figure 4 AI in Oncology Market by Disease Type: Market Attractiveness Index
Figure 5 AI in Oncology Market by End-user: Market Attractiveness Index
Figure 6 AI in Oncology Market Attractiveness Index by Region
Figure 7 AI in Oncology Market: Market Dynamics
Figure 8 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 AI in Oncology Market: Porter’s Five Forces Analysis
Figure 13 AI in Oncology Market: PEST Analysis
Figure 14 AI in Oncology Market by Product Type: Market Attractiveness Index
Figure 15 AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 16 AI in Oncology Market Share Forecast by Product Type, 2023, 2028, 2033 (%)
Figure 17 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Software Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Hardware Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Hardware Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 AI in Oncology Market by Usage Type: Market Attractiveness Index
Figure 24 AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 25 AI in Oncology Market Share Forecast by Usage Type, 2023, 2028, 2033 (%)
Figure 26 Cancer Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Cancer Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Pre-screening and Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Pre-screening and Diagnosis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Treatment Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 AI in Oncology Market by End-user: Market Attractiveness Index
Figure 33 AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 34 AI in Oncology Market Share Forecast by End-user, 2023, 2028, 2033 (%)
Figure 35 Pharmaceutical and Biopharmaceutical Companies Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Hospital and Diagnostic Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Hospital and Diagnostic Centres Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 AI in Oncology Market by Disease Type: Market Attractiveness Index
Figure 44 AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 45 AI in Oncology Market Share Forecast by Disease Type, 2023, 2028, 2033 (%)
Figure 46 Lung Cancer Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 47 Lung Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Breast Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 49 Breast Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Prostate Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 51 Prostate Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Colon Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Colon Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 AI in Oncology Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 57 AI in Oncology Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 58 AI in Oncology Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 North America AI in Oncology Market Attractiveness Index
Figure 60 North America AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 61 North America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 62 North America AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 64 North America AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 65 North America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 66 North America AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 67 North America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 68 North America AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 69 North America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 70 North America AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 71 U.S. AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Canada AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe AI in Oncology Market Attractiveness Index
Figure 74 Europe AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 75 Europe AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 76 Europe AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 78 Europe AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 79 Europe AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 81 Europe AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 83 Europe AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 85 Germany AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 France AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 UK AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Italy AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Spain AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 Russia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 Rest of Europe AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Asia Pacific AI in Oncology Market Attractiveness Index
Figure 93 Asia Pacific AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 94 Asia Pacific AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 95 Asia Pacific AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 Asia Pacific AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 97 Asia Pacific AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 98 Asia Pacific AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia Pacific AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 100 Asia Pacific AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 102 Asia Pacific AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 104 Japan AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 China AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 India AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Australia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 South Korea AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Singapore AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 Rest of Asia Pacific AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Latin America AI in Oncology Market Attractiveness Index
Figure 112 Latin America AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 113 Latin America AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 115 Latin America AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 117 Latin America AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 119 Latin America AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 120 Latin America AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 121 Latin America AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 122 Latin America AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 123 Brazil AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 Mexico AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 Argentina AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Colombia AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Rest of Latin America AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 MEA AI in Oncology Market Attractiveness Index
Figure 129 MEA AI in Oncology Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 130 MEA AI in Oncology Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA AI in Oncology Market Share Forecast by Country, 2023 & 2033 (%)
Figure 132 MEA AI in Oncology Market Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 133 MEA AI in Oncology Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 134 MEA AI in Oncology Market Forecast by Usage Type, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA AI in Oncology Market Share Forecast by Usage Type, 2023 & 2033 (%)
Figure 136 MEA AI in Oncology Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA AI in Oncology Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 138 MEA AI in Oncology Market Forecast by Disease Type, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA AI in Oncology Market Share Forecast by Disease Type, 2023 & 2033 (%)
Figure 140 GCC AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 South Africa AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Rest of MEA AI in Oncology Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 AI in Oncology Market: Company Share/Ranking, 2022
Figure 144 IBM Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 145 IBM: R&D, 2017-2022 (US$ Million, AGR %)
Figure 146 IBM: Regional Market Shares, 2022
Figure 147 GE Healthcare: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 148 GE Healthcare: R&D, 2019-2022 (US$ Million, AGR%)
Figure 149 GE Healthcare: Regional Market Shares, 2022
Figure 150 iCAD: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 151 iCAD: R&D, 2017-2022 (US$ Million, AGR%)
Figure 152 Siemens Healthineers: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 153 Siemens Healthineers: R&D, 2018-2022 (US$ Million, AGR%)
Figure 154 Siemens Healthineers: Product Benchmarking
Figure 155 Siemens Healthineers: Strategic Outlook
Figure 156 Google: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 157 Google: R&D, 2017-2022 (US$ Million, AGR%)
Figure 158 Intel: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 159 Intel: R&D, 2017-2022 (US$ Million, AGR%)
Figure 160 NVIDIA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 161 NVIDIA: R&D, 2017-2022 (US$ Million, AGR%)
Figure 162 NVIDIA: Regional Market Shares, 2022
ページTOPに戻る
本レポートと同じKEY WORD（ai）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
